Fred Alger Management, LLC Medpace Holdings, Inc. Transaction History

Fred Alger Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$372.0 - $424.34 $1.53 Million - $1.74 Million	4,103 New	4,103 $1.69 Million
Q4 2019 Feb 14, 2020	SELL	$70.08 - $84.64 $2.26 Million - $2.73 Million	-32,262 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$62.38 - $85.89 $2.01 Million - $2.77 Million	32,262 New	32,262 $2.71 Million
Q2 2019 Aug 14, 2019	SELL	$53.64 - $65.42 $1.25 Million - $1.52 Million	-23,265 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$49.38 - $70.58 $1.15 Million - $1.64 Million	23,265 New	23,265 $1.37 Million

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.